Cargando…
COVID-19 vaccine challenges: What have we learned so far and what remains to be done?
Developing and distributing a safe and effective SARS-CoV-2 (COVID-19) vaccine has garnered immense global interest. Less than a year after COVID-19 was declared a pandemic, several vaccine candidates had received emergency use authorization across a range of countries. Despite this scientific break...
Autores principales: | Forman, Rebecca, Shah, Soleil, Jeurissen, Patrick, Jit, Mark, Mossialos, Elias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997052/ https://www.ncbi.nlm.nih.gov/pubmed/33820678 http://dx.doi.org/10.1016/j.healthpol.2021.03.013 |
Ejemplares similares
-
Esophageal Mucosal Resistance in Reflux Esophagitis: What We Have Learned So Far and What Remains to Be Learned
por: Maev, Igor V., et al.
Publicado: (2023) -
COVID-19: What We Have Learned So Far
por: Clifford, Theresa
Publicado: (2020) -
Pediatric Myocarditis: What Have We Learnt So Far?
por: Pomiato, Elettra, et al.
Publicado: (2022) -
What we know so far
Publicado: (2021) -
Anabaenopeptins: What We Know So Far
por: Monteiro, Patrick Romano, et al.
Publicado: (2021)